Back

Digitoxin and digoxin: standard therapy for HFrEF?

9 May 2026 (08:30 - 08:45)
Organised by: Logo
Congress Presentation Part of: Controversies in contemporary drug therapy for heart failure Cardiovascular Pharmacotherapy HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Professor Udo Bavendiek

Hannover Medical School, Hannover (Germany)

3 More presentations in this session

Presentation thumbnail
Verigicuat: standard therapy for HFrEF?
Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)
Slides Video
Presentation thumbnail
Non-steroidal mineralocorticoid receptor antagonists (MRAs): standard therapy for HFpEF?
Doctor A. Ruwald (Copenhagen, DK)
Slides Video
Presentation thumbnail
Controversies in contemporary drug therapy for heart failure - discussion
Video

Access the full session

Session thumbnail
Controversies in contemporary drug therapy for heart failure
Video

The Event

Event poster

Heart Failure 2026

9 May 2026 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Discussant review - DECISION/DIGIT-HF/DIG Meta Analysis
thumbnail
Congress Session
Hottest trials (2)
thumbnail
Congress Presentation
HFA Philip Poole Wilson Lecture - Digoxin in heart failure: the past, the present and the possible future

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources